Cart
sales@molnova.com
OGT inhibitor 4a
CAS No. 2411972-44-4
OGT inhibitor 4a( —— )
Catalog No. M37599 CAS No. 2411972-44-4
OGT inhibitor 4a is an O-linked n-acetylglucosaminyltransferase (OGT) inhibitor with anticancer activity for the study of autoimmune and neurological disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 516 | In Stock |
|
| 10MG | 773 | In Stock |
|
| 25MG | 1311 | In Stock |
|
| 50MG | 1934 | In Stock |
|
| 100MG | 2892 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOGT inhibitor 4a
-
NoteResearch use only, not for human use.
-
Brief DescriptionOGT inhibitor 4a is an O-linked n-acetylglucosaminyltransferase (OGT) inhibitor with anticancer activity for the study of autoimmune and neurological disorders.
-
DescriptionOGT inhibitor 4a is an O-linked n-acetylglucosaminyltransferase (OGT) inhibitor with anticancer activity for the study of autoimmune and neurological disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2411972-44-4
-
Formula Weight576.04
-
Molecular FormulaC25H22ClN3O7S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@@H](C(N(CC1=CC=CS1)CC(O)=O)=O)(NS(=O)(=O)C=2C=C3C(=CC2Cl)NC(=O)C=C3)C4=C(OC)C=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Tosufloxacin p-Tolue...
Tosufloxacin p-Toluenesulfonate Hydrate is a fluoroquinolone antibacterial agent that is used to treat susceptible infections.
-
16,17-Didehydroganod...
3,11,15,23-Tetraoxo-27ξ-lanosta-8,16-dien-26-oic acid, a lanostane-type triterpenoid, is isolated from Antrodia camphorate.
-
AA92593
AA92593 has been used as a selective inhibitor of melanopsin.The involvement of melanopsin in the regulation of melatonin was also determined by using a specific inhibitor AA92593 and by inhibiting melanopsin-induced phospholipase C activation.
